Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia
Acinetobacter baumannii has emerged as a problematic multidrug-resistant (MDR) pathogen worldwide. The aim of this study was to characterize clinical isolates of A. baumannii from Jeddah, a coastal city in the western region of Saudi Arabia that has an ∼50% expatriate population. In this study, 135...
Gespeichert in:
| Veröffentlicht in: | Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2019-11, Vol.25 (9), p.1297-1305 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1305 |
|---|---|
| container_issue | 9 |
| container_start_page | 1297 |
| container_title | Microbial drug resistance (Larchmont, N.Y.) |
| container_volume | 25 |
| creator | Shah, Muhammad Waseem Yasir, Muhammad Farman, Muhammad Jiman-Fatani, Asif A. Almasaudi, Saad B. Alawi, Maha El-Hossary, Dalia Azhar, Esam I. |
| description | Acinetobacter baumannii
has emerged as a problematic multidrug-resistant (MDR) pathogen worldwide. The aim of this study was to characterize clinical isolates of
A. baumannii
from Jeddah, a coastal city in the western region of Saudi Arabia that has an ∼50% expatriate population. In this study, 135 nonrepetitive clinical isolates of
A. baumannii
were identified through MALDI-TOF and susceptibility was determined with VITEK-2 systems and broth microdilution method. Genotypic characterization of the isolates was performed by using M13 primer typing and polymerase chain reaction screening was performed for carbapenemase genes, insertion sequences, metallo-β-lactamases, and cephalosporinase genes. The isolates were recovered from heterogeneous clinical specimens, and the majority of the cases of
A. baumannii
infection were acquired in the hospital and predominantly involved patients who were older than 50 years. Total, 58.5% of the isolates were MDR, and 55.6% isolates were resistant to carbapenem antibiotics. Approximately half of the isolates were resistant to ceftazidime, and cefepime among the β-lactam antibiotics and ciprofloxacin from the quinolone group. The
bla
OXA-23-like
gene and IS
Aba1
upstream of
bla
OXA-23-like
were detected in 92% of the carbapenem-resistant isolates, while all carbapenem-resistant isolates were found to carry
bla
OXA-51-like,
and
bla
ADC
-type cephalosporinase gene. The
bla
IMP
gene was detected in 84% isolates, and two isolates carried the
bla
NDM-1
gene. Data demonstrate the coexistence of multiple carbapenem resistance determinants in
A. baumannii
from the western region of Saudi Arabia. |
| doi_str_mv | 10.1089/mdr.2019.0018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2311096790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2311096790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-1b09d0daa7e71a298e5f961ddee4afd786200cdfa3de0b44dc6de20db53f2fbe3</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi0Eoh9w7LWyxDnbsZ114uNqRaFSKw4FcYzGHxFTJc7iOIf2yC-vw5ZeOc3o1eN3rIexCwEbAa25Gn3aSBBmAyDaN-xUGCWqtq7bt2WHRldamvqEnc3zAwBshVbv2YkSUmgpxSn7s4uZRnJpsoQDv19mFw6ZLA2UHzlGz--mIbhlwMT3vzChyyHRE2aaIp96vh8okltf5oQU5zXbOYohT_Yvyy0uI8ZIxCnyn2EuWeT3uHjiu4Tl6gf2rsdhDh9f5jn7cf35-_5rdfvty81-d1s5pbe5EhaMB4_YhEagNG3Y9kYL70OosfdNqyWA8z0qH8DWtXfaBwneblUvexvUOft07D2k6fdSPtI9TEuK5WQnlRBgdGOgUNWRKkrmOYW-OyQaMT12ArrVeFeMd6vxbjVe-MuX1sWOwb_S_xQXQB2BNS4iBgo2pPyf2meS9ZDs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2311096790</pqid></control><display><type>article</type><title>Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shah, Muhammad Waseem ; Yasir, Muhammad ; Farman, Muhammad ; Jiman-Fatani, Asif A. ; Almasaudi, Saad B. ; Alawi, Maha ; El-Hossary, Dalia ; Azhar, Esam I.</creator><creatorcontrib>Shah, Muhammad Waseem ; Yasir, Muhammad ; Farman, Muhammad ; Jiman-Fatani, Asif A. ; Almasaudi, Saad B. ; Alawi, Maha ; El-Hossary, Dalia ; Azhar, Esam I.</creatorcontrib><description>Acinetobacter baumannii
has emerged as a problematic multidrug-resistant (MDR) pathogen worldwide. The aim of this study was to characterize clinical isolates of
A. baumannii
from Jeddah, a coastal city in the western region of Saudi Arabia that has an ∼50% expatriate population. In this study, 135 nonrepetitive clinical isolates of
A. baumannii
were identified through MALDI-TOF and susceptibility was determined with VITEK-2 systems and broth microdilution method. Genotypic characterization of the isolates was performed by using M13 primer typing and polymerase chain reaction screening was performed for carbapenemase genes, insertion sequences, metallo-β-lactamases, and cephalosporinase genes. The isolates were recovered from heterogeneous clinical specimens, and the majority of the cases of
A. baumannii
infection were acquired in the hospital and predominantly involved patients who were older than 50 years. Total, 58.5% of the isolates were MDR, and 55.6% isolates were resistant to carbapenem antibiotics. Approximately half of the isolates were resistant to ceftazidime, and cefepime among the β-lactam antibiotics and ciprofloxacin from the quinolone group. The
bla
OXA-23-like
gene and IS
Aba1
upstream of
bla
OXA-23-like
were detected in 92% of the carbapenem-resistant isolates, while all carbapenem-resistant isolates were found to carry
bla
OXA-51-like,
and
bla
ADC
-type cephalosporinase gene. The
bla
IMP
gene was detected in 84% isolates, and two isolates carried the
bla
NDM-1
gene. Data demonstrate the coexistence of multiple carbapenem resistance determinants in
A. baumannii
from the western region of Saudi Arabia.</description><identifier>ISSN: 1076-6294</identifier><identifier>EISSN: 1931-8448</identifier><identifier>DOI: 10.1089/mdr.2019.0018</identifier><identifier>PMID: 31216221</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc., publishers</publisher><subject>Acinetobacter baumannii ; Acinetobacter baumannii - drug effects ; Acinetobacter baumannii - genetics ; Acinetobacter baumannii - isolation & purification ; Acinetobacter Infections - drug therapy ; Acinetobacter Infections - epidemiology ; Acinetobacter Infections - microbiology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Amides ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Antimicrobial agents ; Bacterial Proteins - genetics ; beta-Lactamases - genetics ; Carbapenemase ; Carbapenems - pharmacology ; Cefepime ; Ceftazidime ; Cephalosporinase ; Child ; Child, Preschool ; Ciprofloxacin ; Clinical isolates ; Coexistence ; Drug Resistance, Multiple, Bacterial ; Epidemiology ; Female ; Gene sequencing ; Genes ; Humans ; Infant ; Infant, Newborn ; Insertion sequences ; Male ; Metallography ; Microbial Sensitivity Tests ; Middle Aged ; Multidrug resistance ; Polymerase chain reaction ; Population studies ; Saudi Arabia ; Young Adult ; β-Lactam antibiotics</subject><ispartof>Microbial drug resistance (Larchmont, N.Y.), 2019-11, Vol.25 (9), p.1297-1305</ispartof><rights>2019, Mary Ann Liebert, Inc., publishers</rights><rights>Copyright Mary Ann Liebert, Inc. Nov 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-1b09d0daa7e71a298e5f961ddee4afd786200cdfa3de0b44dc6de20db53f2fbe3</citedby><cites>FETCH-LOGICAL-c365t-1b09d0daa7e71a298e5f961ddee4afd786200cdfa3de0b44dc6de20db53f2fbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31216221$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, Muhammad Waseem</creatorcontrib><creatorcontrib>Yasir, Muhammad</creatorcontrib><creatorcontrib>Farman, Muhammad</creatorcontrib><creatorcontrib>Jiman-Fatani, Asif A.</creatorcontrib><creatorcontrib>Almasaudi, Saad B.</creatorcontrib><creatorcontrib>Alawi, Maha</creatorcontrib><creatorcontrib>El-Hossary, Dalia</creatorcontrib><creatorcontrib>Azhar, Esam I.</creatorcontrib><title>Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia</title><title>Microbial drug resistance (Larchmont, N.Y.)</title><addtitle>Microb Drug Resist</addtitle><description>Acinetobacter baumannii
has emerged as a problematic multidrug-resistant (MDR) pathogen worldwide. The aim of this study was to characterize clinical isolates of
A. baumannii
from Jeddah, a coastal city in the western region of Saudi Arabia that has an ∼50% expatriate population. In this study, 135 nonrepetitive clinical isolates of
A. baumannii
were identified through MALDI-TOF and susceptibility was determined with VITEK-2 systems and broth microdilution method. Genotypic characterization of the isolates was performed by using M13 primer typing and polymerase chain reaction screening was performed for carbapenemase genes, insertion sequences, metallo-β-lactamases, and cephalosporinase genes. The isolates were recovered from heterogeneous clinical specimens, and the majority of the cases of
A. baumannii
infection were acquired in the hospital and predominantly involved patients who were older than 50 years. Total, 58.5% of the isolates were MDR, and 55.6% isolates were resistant to carbapenem antibiotics. Approximately half of the isolates were resistant to ceftazidime, and cefepime among the β-lactam antibiotics and ciprofloxacin from the quinolone group. The
bla
OXA-23-like
gene and IS
Aba1
upstream of
bla
OXA-23-like
were detected in 92% of the carbapenem-resistant isolates, while all carbapenem-resistant isolates were found to carry
bla
OXA-51-like,
and
bla
ADC
-type cephalosporinase gene. The
bla
IMP
gene was detected in 84% isolates, and two isolates carried the
bla
NDM-1
gene. Data demonstrate the coexistence of multiple carbapenem resistance determinants in
A. baumannii
from the western region of Saudi Arabia.</description><subject>Acinetobacter baumannii</subject><subject>Acinetobacter baumannii - drug effects</subject><subject>Acinetobacter baumannii - genetics</subject><subject>Acinetobacter baumannii - isolation & purification</subject><subject>Acinetobacter Infections - drug therapy</subject><subject>Acinetobacter Infections - epidemiology</subject><subject>Acinetobacter Infections - microbiology</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amides</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacterial Proteins - genetics</subject><subject>beta-Lactamases - genetics</subject><subject>Carbapenemase</subject><subject>Carbapenems - pharmacology</subject><subject>Cefepime</subject><subject>Ceftazidime</subject><subject>Cephalosporinase</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Ciprofloxacin</subject><subject>Clinical isolates</subject><subject>Coexistence</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Gene sequencing</subject><subject>Genes</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Insertion sequences</subject><subject>Male</subject><subject>Metallography</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Multidrug resistance</subject><subject>Polymerase chain reaction</subject><subject>Population studies</subject><subject>Saudi Arabia</subject><subject>Young Adult</subject><subject>β-Lactam antibiotics</subject><issn>1076-6294</issn><issn>1931-8448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhi0Eoh9w7LWyxDnbsZ114uNqRaFSKw4FcYzGHxFTJc7iOIf2yC-vw5ZeOc3o1eN3rIexCwEbAa25Gn3aSBBmAyDaN-xUGCWqtq7bt2WHRldamvqEnc3zAwBshVbv2YkSUmgpxSn7s4uZRnJpsoQDv19mFw6ZLA2UHzlGz--mIbhlwMT3vzChyyHRE2aaIp96vh8okltf5oQU5zXbOYohT_Yvyy0uI8ZIxCnyn2EuWeT3uHjiu4Tl6gf2rsdhDh9f5jn7cf35-_5rdfvty81-d1s5pbe5EhaMB4_YhEagNG3Y9kYL70OosfdNqyWA8z0qH8DWtXfaBwneblUvexvUOft07D2k6fdSPtI9TEuK5WQnlRBgdGOgUNWRKkrmOYW-OyQaMT12ArrVeFeMd6vxbjVe-MuX1sWOwb_S_xQXQB2BNS4iBgo2pPyf2meS9ZDs</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Shah, Muhammad Waseem</creator><creator>Yasir, Muhammad</creator><creator>Farman, Muhammad</creator><creator>Jiman-Fatani, Asif A.</creator><creator>Almasaudi, Saad B.</creator><creator>Alawi, Maha</creator><creator>El-Hossary, Dalia</creator><creator>Azhar, Esam I.</creator><general>Mary Ann Liebert, Inc., publishers</general><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>20191101</creationdate><title>Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia</title><author>Shah, Muhammad Waseem ; Yasir, Muhammad ; Farman, Muhammad ; Jiman-Fatani, Asif A. ; Almasaudi, Saad B. ; Alawi, Maha ; El-Hossary, Dalia ; Azhar, Esam I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-1b09d0daa7e71a298e5f961ddee4afd786200cdfa3de0b44dc6de20db53f2fbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acinetobacter baumannii</topic><topic>Acinetobacter baumannii - drug effects</topic><topic>Acinetobacter baumannii - genetics</topic><topic>Acinetobacter baumannii - isolation & purification</topic><topic>Acinetobacter Infections - drug therapy</topic><topic>Acinetobacter Infections - epidemiology</topic><topic>Acinetobacter Infections - microbiology</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amides</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacterial Proteins - genetics</topic><topic>beta-Lactamases - genetics</topic><topic>Carbapenemase</topic><topic>Carbapenems - pharmacology</topic><topic>Cefepime</topic><topic>Ceftazidime</topic><topic>Cephalosporinase</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Ciprofloxacin</topic><topic>Clinical isolates</topic><topic>Coexistence</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Gene sequencing</topic><topic>Genes</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Insertion sequences</topic><topic>Male</topic><topic>Metallography</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Multidrug resistance</topic><topic>Polymerase chain reaction</topic><topic>Population studies</topic><topic>Saudi Arabia</topic><topic>Young Adult</topic><topic>β-Lactam antibiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Muhammad Waseem</creatorcontrib><creatorcontrib>Yasir, Muhammad</creatorcontrib><creatorcontrib>Farman, Muhammad</creatorcontrib><creatorcontrib>Jiman-Fatani, Asif A.</creatorcontrib><creatorcontrib>Almasaudi, Saad B.</creatorcontrib><creatorcontrib>Alawi, Maha</creatorcontrib><creatorcontrib>El-Hossary, Dalia</creatorcontrib><creatorcontrib>Azhar, Esam I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Muhammad Waseem</au><au>Yasir, Muhammad</au><au>Farman, Muhammad</au><au>Jiman-Fatani, Asif A.</au><au>Almasaudi, Saad B.</au><au>Alawi, Maha</au><au>El-Hossary, Dalia</au><au>Azhar, Esam I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia</atitle><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle><addtitle>Microb Drug Resist</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>25</volume><issue>9</issue><spage>1297</spage><epage>1305</epage><pages>1297-1305</pages><issn>1076-6294</issn><eissn>1931-8448</eissn><abstract>Acinetobacter baumannii
has emerged as a problematic multidrug-resistant (MDR) pathogen worldwide. The aim of this study was to characterize clinical isolates of
A. baumannii
from Jeddah, a coastal city in the western region of Saudi Arabia that has an ∼50% expatriate population. In this study, 135 nonrepetitive clinical isolates of
A. baumannii
were identified through MALDI-TOF and susceptibility was determined with VITEK-2 systems and broth microdilution method. Genotypic characterization of the isolates was performed by using M13 primer typing and polymerase chain reaction screening was performed for carbapenemase genes, insertion sequences, metallo-β-lactamases, and cephalosporinase genes. The isolates were recovered from heterogeneous clinical specimens, and the majority of the cases of
A. baumannii
infection were acquired in the hospital and predominantly involved patients who were older than 50 years. Total, 58.5% of the isolates were MDR, and 55.6% isolates were resistant to carbapenem antibiotics. Approximately half of the isolates were resistant to ceftazidime, and cefepime among the β-lactam antibiotics and ciprofloxacin from the quinolone group. The
bla
OXA-23-like
gene and IS
Aba1
upstream of
bla
OXA-23-like
were detected in 92% of the carbapenem-resistant isolates, while all carbapenem-resistant isolates were found to carry
bla
OXA-51-like,
and
bla
ADC
-type cephalosporinase gene. The
bla
IMP
gene was detected in 84% isolates, and two isolates carried the
bla
NDM-1
gene. Data demonstrate the coexistence of multiple carbapenem resistance determinants in
A. baumannii
from the western region of Saudi Arabia.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc., publishers</pub><pmid>31216221</pmid><doi>10.1089/mdr.2019.0018</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1076-6294 |
| ispartof | Microbial drug resistance (Larchmont, N.Y.), 2019-11, Vol.25 (9), p.1297-1305 |
| issn | 1076-6294 1931-8448 |
| language | eng |
| recordid | cdi_proquest_journals_2311096790 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Acinetobacter baumannii Acinetobacter baumannii - drug effects Acinetobacter baumannii - genetics Acinetobacter baumannii - isolation & purification Acinetobacter Infections - drug therapy Acinetobacter Infections - epidemiology Acinetobacter Infections - microbiology Adolescent Adult Aged Aged, 80 and over Amides Anti-Bacterial Agents - pharmacology Antibiotics Antimicrobial agents Bacterial Proteins - genetics beta-Lactamases - genetics Carbapenemase Carbapenems - pharmacology Cefepime Ceftazidime Cephalosporinase Child Child, Preschool Ciprofloxacin Clinical isolates Coexistence Drug Resistance, Multiple, Bacterial Epidemiology Female Gene sequencing Genes Humans Infant Infant, Newborn Insertion sequences Male Metallography Microbial Sensitivity Tests Middle Aged Multidrug resistance Polymerase chain reaction Population studies Saudi Arabia Young Adult β-Lactam antibiotics |
| title | Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A55%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20Susceptibility%20and%20Molecular%20Characterization%20of%20Clinical%20Strains%20of%20Acinetobacter%20baumannii%20in%20Western%20Saudi%20Arabia&rft.jtitle=Microbial%20drug%20resistance%20(Larchmont,%20N.Y.)&rft.au=Shah,%20Muhammad%20Waseem&rft.date=2019-11-01&rft.volume=25&rft.issue=9&rft.spage=1297&rft.epage=1305&rft.pages=1297-1305&rft.issn=1076-6294&rft.eissn=1931-8448&rft_id=info:doi/10.1089/mdr.2019.0018&rft_dat=%3Cproquest_cross%3E2311096790%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2311096790&rft_id=info:pmid/31216221&rfr_iscdi=true |